Clinical Trial Update: Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia [NA]

View source ↗

Summary

A clinical trial evaluating the use of granulocyte colony-stimulating factor (G-CSF) in post Kasai Type 3 biliary atresia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Atresia

Drugs mentioned

• Granulocyte Colony Stimulating Factor (granulocyte colony-stimulating factor (G-CSF))

Snippet

Sponsor: National Liver Institute, Egypt | Conditions: Granulocyte Colony-stimulating Factor, Biliary Atresia | NA | Status: RECRUITING